• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

JenaValve

JenaValve appoints new chief commercial officer

September 28, 2020 By Chris Newmarker

JenaValve Technology has appointed Peter L. Spadaro Jr. to the newly created position of chief commercial 0fficer. Spadaro is an experienced cardiovascular sales and marketing executive who has held senior positions at industry giants including Medtronic, St. Jude Medical and most recently Syncardia. “Peter’s proven success in all aspects of launching and commercializing innovative structural […]

Filed Under: Business/Financial News, Cardiovascular, Replacement Heart Valves Tagged With: JenaValve, Personnel Moves

JenaValve raises $50m for TAVR tech

February 13, 2020 By Sean Whooley

JenaValve Technology announced that it raised $50 million in equity financing as it develops and manufactures the JenaValve pericardial transcatheter aortic valve replacement (TAVR) system for treating aortic valve disease. Bain Capital Life Sciences led the funding round, while Andera Partners, Gimv, Legend Capital, NoMed Management, RMM, Valiance Life Sciences and VI Partners all participated, […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Funding Roundup, Replacement Heart Valves Tagged With: JenaValve, Personnel Moves, tavr

JenaValve TAVR wins FDA breakthrough device designation

January 9, 2020 By Chris Newmarker

JenaValve Technology said today that FDA has granted breakthrough device designation for its JenaValve Pericardial TAVR. The designation is for severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease. It means that FDA will provide the Irvine, Calif.–based company with priority review and interactive communication regarding device development and clinical trial protocols. “We are […]

Filed Under: Cardiovascular, Featured, News Well, Regulatory/Compliance, Replacement Heart Valves Tagged With: JenaValve, tavr

Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019

September 19, 2019 By Brad Perriello

Dexcom (NSDQ:DXCM) this week added the COO role to CFO Quentin Blackford’s title. Blackford is now in charge of Dexcom’s global supply chain, manufacturing operations and expansion into new markets, the San Diego-based company said. He’s been CFO of the continuous glucose monitor maker since 2017, when he left the chief finance spot at NuVasive (NSDQ:NUVA). […]

Filed Under: Business/Financial News, Featured Tagged With: BioVentrix, Cerner Corp., Dexcom, Everlife, JenaValve, MediSpend, microdermics, Personnel Moves, saranas, SetPoint Medical, SQZ Biotech, Stereotaxis, Zimmer Biomet

JenaValve adds $15m for TAVR device

June 21, 2019 By Brad Perriello

JenaValve Technology said yesterday that it raised nearly $15 million for the transcatheter aortic valve replacement it’s developing. The Irvine, Calif.-based company makes the the Everdur valve and Coronatix delivery catheter to treat aortic stenosis and aortic regurgitation. In a regulatory filing, JenaValve said it pulled in $14.5 million in an equity round that began […]

Filed Under: Cardiovascular, Catheters, Featured, Funding Roundup, Replacement Heart Valves, Wall Street Beat Tagged With: JenaValve

JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019

January 15, 2019 By Fink Densford

JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]

Filed Under: Business/Financial News, Featured Tagged With: apyxmedical, biogennix, Cardiac Dimensions, Cardiovascular Systems Inc., Coorstek, Covidien, DaVita Inc., Digirad Corp., Endologix, ev3 Inc., Integra LifeSciences, Intuitive Surgical, InVivo Therapeutics, JenaValve, Johnson and Johnson, Medtronic, mentice, Micrus Endovascular Corp., Natus Medical Inc., Outset Medical, Patterson Companies, ReVision Optics Inc., Solace Therapeutics, Sonova Holding AG, Xtant Medical

FDA OKs expanded JenaValve study

December 3, 2018 By Brad Perriello

JenaValve Technology said today that the FDA approved the expansion of its investigational device exemption trials for the transcatheter aortic valve replacement it’s developing. The JenaValve system consists of the Everdur valve and Coronatix delivery catheter. The FDA decision expands the feasibility study from 20 extreme- or high-risk patients to 80 patients with either aortic stenosis or […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves Tagged With: JenaValve

JenaValve launches feasibility study of next-gen pericardial TAVR system

August 3, 2018 By Fink Densford

JenaValve Technology said today it launched an FDA investigational device exemption cleared early feasibility study of its next generation JenaValve pericardial transcatheter aortic valve replacement system. The newly launched trial will explore the use of the device as a minimally invasive treatment for patients with symptomatic, severe aortic stenosis and symptomatic aortic regurgitation in patients who […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: JenaValve

JenaValve launches CE Mark study of next-gen TAVR system

June 21, 2018 By Fink Densford

JenaValve Technology said this week it launched a new study of its next-generation pericardial transcatheter aortic valve replacement systems using its Coronatix transfemoral delivery catheter. In the newly launched trial, the Irvine, Calif.-based company will explore the use of the system as a treatment for severe aortic regurgitation in patients who are at high risk for […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Replacement Heart Valves Tagged With: JenaValve

JenaValve raises $5m

February 6, 2018 By Fink Densford

JenaValve Technology has raised $4.9 million in a new round of debt financing, according to an SEC filing posted this week. The Irvine, Calif.-based company is one of several smaller players looking to enter the transcatheter aortic valve implant space as it challenges major players Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and Boston Scientific (NYSE:BSX). JenaValve has not yet […]

Filed Under: Business/Financial News, Funding Roundup Tagged With: JenaValve

LimFlow taps Rose for CEO | Personnel Moves

October 21, 2016 By Fink Densford

LimFlow taps ex-Direct Flow GM Rose as CEO LimFlow said this week that it tapped former Direct Flow Medical VP and GM Daniel Rose as its new chief executive, with former co-founder & CEO Timothy Lenihan transitioning to chief technology officer. LimFlow is developing a device to create percutaneous venous arterialization in the foot to treat end-stage critical limb […]

Filed Under: Business/Financial News Tagged With: becton dickinson, Boston Scientific, CareFusion Corp., Direct Flow Medical Inc., Dynatronics Corp, EnteroMedics Inc., Farm Design Inc., Insulet, integer, JenaValve, LimFlow, Nuvasive, Organogenesis Inc., Personnel Moves

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS